Global Peptide Receptor Radionuclide Therapy (PRRT) Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 32569
  • calendar_today Published On: Apr, 2020
  • file_copy Pages: 102
  • list Pharmaceuticals and Healthcare
Buy @ $3480
Description

Scope of the Report:
The global Peptide Receptor Radionuclide Therapy (PRRT) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Peptide Receptor Radionuclide Therapy (PRRT).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Peptide Receptor Radionuclide Therapy (PRRT) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Peptide Receptor Radionuclide Therapy (PRRT) market by product type and applications/end industries.

Market Segment by Companies, this report covers
Novartis
Australasian Gastro-Intestinal Trials Group
ITM Solucin
National Institutes of Health

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Gastroenteropancreatic Neuroendocrine Tumor
Foregut Neuroendocrine Tumor
Midgut Neuroendocrine Tumor
Hindgut Neuroendocrine Tumor

Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents
1 Peptide Receptor Radionuclide Therapy (PRRT) Market Overview
1.1 Product Overview and Scope of Peptide Receptor Radionuclide Therapy (PRRT)
1.2 Classification of Peptide Receptor Radionuclide Therapy (PRRT) by Types
1.2.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Comparison by Types (2019-2024)
1.2.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Types in 2018
1.2.3 Gastroenteropancreatic Neuroendocrine Tumor
1.2.4 Foregut Neuroendocrine Tumor
1.2.5 Midgut Neuroendocrine Tumor
1.2.6 Hindgut Neuroendocrine Tumor
1.3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Application
1.3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market by Regions
1.4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Peptide Receptor Radionuclide Therapy (PRRT) Status and Prospect (2014-2024)
1.5 Global Market Size of Peptide Receptor Radionuclide Therapy (PRRT) (2014-2024)
2 Company Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
2.2 Australasian Gastro-Intestinal Trials Group
2.2.1 Business Overview
2.2.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
2.3 ITM Solucin
2.3.1 Business Overview
2.3.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
2.4 National Institutes of Health
2.4.1 Business Overview
2.4.2 Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Competition, by Players
3.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share
3.2.2 Top 10 Peptide Receptor Radionuclide Therapy (PRRT) Players Market Share
3.3 Market Competition Trend
4 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size by Regions
4.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Market Share by Regions
4.2 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
4.3 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
4.5 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
5 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
5.1 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
5.2 USA Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
5.3 Canada Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
5.4 Mexico Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
6.1 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
6.2 Germany Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6.3 UK Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6.4 France Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6.5 Russia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
6.6 Italy Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
7.1 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
7.2 China Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7.3 Japan Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7.4 Korea Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7.5 India Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
8 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries
8.1 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
8.2 Brazil Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
8.3 Argentina Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
8.4 Colombia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Peptide Receptor Radionuclide Therapy (PRRT) by Countries
9.1 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9.3 UAE Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9.4 Egypt Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
9.6 South Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
10 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment by Type
10.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Market Share by Type (2014-2019)
10.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Type (2019-2024)
10.3 Gastroenteropancreatic Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
10.4 Foregut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
10.5 Midgut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
10.6 Hindgut Neuroendocrine Tumor Revenue Growth Rate (2014-2024)
11 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Segment by Application
11.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Application (2014-2019)
11.2 Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Application (2019-2024)
11.3 Hospital Pharmacies Revenue Growth (2014-2019)
11.4 Retail Pharmacies Revenue Growth (2014-2019)
11.5 Online Pharmacies Revenue Growth (2014-2019)
12 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast (2019-2024)
12.1 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Size Forecast (2019-2024)
12.2 Global Peptide Receptor Radionuclide Therapy (PRRT) Market Forecast by Regions (2019-2024)
12.3 North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
12.4 Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
12.6 South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Peptide Receptor Radionuclide Therapy (PRRT) Picture
Table Product Specifications of Peptide Receptor Radionuclide Therapy (PRRT)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) and Revenue (Million USD) Market Split by Product Type
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Types in 2018
Figure Gastroenteropancreatic Neuroendocrine Tumor Picture
Figure Foregut Neuroendocrine Tumor Picture
Figure Midgut Neuroendocrine Tumor Picture
Figure Hindgut Neuroendocrine Tumor Picture
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Application (2014-2024)
Figure Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Table Global Market Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (2014-2024)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
Table Novartis Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
Table Australasian Gastro-Intestinal Trials Group Basic Information, Manufacturing Base and Competitors
Table Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
Table Australasian Gastro-Intestinal Trials Group Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
Table ITM Solucin Basic Information, Manufacturing Base and Competitors
Table ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
Table ITM Solucin Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
Table National Institutes of Health Basic Information, Manufacturing Base and Competitors
Table National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Type and Applications
Table National Institutes of Health Peptide Receptor Radionuclide Therapy (PRRT) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Players (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Players (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Players in 2017
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Players in 2018
Figure Global Top 5 Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share in 2018
Figure Global Top 10 Players Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share in 2018
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Regions (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Regions (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Regions (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Regions in 2018
Figure North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
Table North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries in 2018
Figure USA Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Canada Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Mexico Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries in 2018
Figure Germany Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure UK Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure France Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Russia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Italy Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries in 2018
Figure China Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Japan Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Korea Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure India Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Countries (2014-2019)
Table South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries in 2018
Figure Brazil Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Argentina Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Colombia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure UAE Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Egypt Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure Nigeria Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Figure South Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue and Growth Rate (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) by Type (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Type (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Type (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Type in 2018
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Forecast by Type (2019-2024)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share Forecast by Type (2019-2024)
Figure Global Gastroenteropancreatic Neuroendocrine Tumor Revenue Growth Rate (2014-2019)
Figure Global Foregut Neuroendocrine Tumor Revenue Growth Rate (2014-2019)
Figure Global Midgut Neuroendocrine Tumor Revenue Growth Rate (2014-2019)
Figure Global Hindgut Neuroendocrine Tumor Revenue Growth Rate (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue by Application (2014-2019)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Application (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Application (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Share by Application in 2018
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Forecast by Application (2019-2024)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Market Share Forecast by Application (2019-2024)
Figure Global Hospital Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Retail Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Online Pharmacies Revenue Growth Rate (2014-2019)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
Figure Europe Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
Figure South America Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Peptide Receptor Radionuclide Therapy (PRRT) Revenue Market Forecast (2019-2024)